[Follow-up study of 66 cases with metastatic liver cancer treated with the Maruyama vaccine--conditions for their survival].
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000276:immunology*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000276:immunology*
D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial